| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |